Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal for Immunotherapy of Cancer|December 15, 2022
Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switchAnnelisa M Cornel, Ester Dunnebach, Damon A Hofman, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2025
Blocking MIF secretion enhances CAR T-cell efficacy against neuroblastomaJosephine G M Strijker, Guillem Pascual-Pasto, Grant P Grothusen, et al.
Rheumatology (Oxford, England)|August 19, 2020
Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular riskJudith Wienke, Jorre S Mertens, Samuel Garcia, et al.
Nature Communications|August 5, 2025
Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector functionMarta Barisa, Henrike P Muller, Elisa Zappa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 13, 2019
Galectin-9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort ValidationJudith Wienke, Felicitas Bellutti Enders, Johan Lim, et al.
Pediatric Blood & Cancer|June 13, 2025
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy ForumSteven G DuBois, Lucas Moreno, John Anderson, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2025
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicineKarin P S Langenberg, Sander R van Hooff, Bianca Koopmans, et al.
Cancer Cell|January 5, 2024
Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapyJudith Wienke, Lindy L Visser, Waleed M Kholosy, et al.
Pageof 3